Navigation Links
Amarantus BioSciences Announces MANF Demonstrates Superiority over GDNF in Neurorestoration Behavioural Animal Model of Parkinson's Disease
Date:10/25/2012

SUNNYVALE, Calif., Oct. 25, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCQB: AMBS), a biotechnology company developing new disease-modifying treatments and diagnostics for Parkinson's disease and Traumatic Brain Injury centred on its proprietary anti-apoptosis therapeutic protein MANF, today announced that the Company has received positive behavioural efficacy data for MANF in a neurorestoration 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease. The data shows superiority of MANF over GDNF, a neurotrophic factor currently in a Phase 2 clinical trial as a disease-modifying treatment for Parkinson's disease, by demonstrating that when MANF is delivered directly to the primary brain region associated with Parkinson's called the substantia nigra, MANF significantly reduced behavioural deficits in the model, whereas GDNF did not. 

In Parkinson's disease, the nigro-striatal network (substantia nigra – striatum) is compromised due to the degeneration of dopaminergic neurons in the substantia nigra, which results in dopaminergic nerve terminal retraction from the striatum towards the substantia nigra. This leaves the striatum with inadequate dopamine levels, which in turn causes motor function deficits and other symptoms. Currently approved drugs that relieve symptoms focus on replacing the dopamine lost in the striatum; however, the symptom relief is temporary and the drugs typically lose their ability to abate symptoms roughly 7-10 years after the initiation of drug therapy. There are no approved therapies that focus on re-innervating the striatum by protecting dopaminergic neuron cell bodies in the substantia nigra while restoring dopaminergic innervation in the striatum.

In rat studies conducted by an independent academic laboratory contracted by Amarantus, 6-OHDA was injected directly into the striatum on one side of each rat's brain, causing their dopaminergic terminals to retract from the striatum towards the substantia
'/>"/>

SOURCE Amarantus BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
2. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
3. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
4. Neurocrine Biosciences Reports First Quarter 2012 Results
5. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
8. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
9. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
10. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... and NOTTINGHAM, England , Oct. 1, ... ) today announced that its subsidiary, Molecular Profiles Ltd., ... platform at the annual CPhI/ICSE Worldwide event in ... support companies with the rapid development of both standard ... technologies screening platform, which incorporates the company,s existing formulation ...
(Date:10/1/2014)... , Oct. 1, 2014  Varian Medical Systems ... will report results for the fourth quarter of fiscal ... Wednesday, October 22, 2014.  The news release will be ... at 2:00 p.m. PT.  The news release and a ... on the company website at: www.varian.com/investor .  To ...
(Date:10/1/2014)... , Oct. 1, 2014  SI-BONE, Inc., a medical device ... ® a minimally invasive surgical (MIS) device indicated for ... announced the expansion of its European operations with the formation ... Schaber as General Manager, Germany.  Mr. Schaber will join ... of Europe , Middle East ...
Breaking Medicine Technology:Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 2Columbia Laboratories' UK Subsidiary To Launch New Development Platform At CPHI 3Varian Medical Systems Schedules Fourth Quarter FY2014 News Release and Conference Call 2SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 2SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 3SI-BONE, Inc. Announces European Expansion with Appointment of Eric Schaber as General Manager, Germany and Formation of GmbH 4
... Md., April 26, 2012 /PRNewswire-Asia/ -- Chindex International, Inc. (NASDAQ: ... providing health care services in China through the operations ... care hospitals and affiliated ambulatory clinics, today announced that ... first quarter of 2012 ended March 31, 2012 on ...
... 2012 Medical sales recruitment specialists Advance ... new global medical device survey for 2012-2013 suggesting a ... climate. The report, which was published this ... a highly detailed analysis drawn from ICD research,s panel ...
Cached Medicine Technology:Chindex International, Inc. to Report First Quarter 2012 Financial Results 2Advance Recruitment Delighted With Positive Outlook for Medical Device Sales Industry 2
(Date:10/1/2014)... 2014) Despite a policy focus on expanding ... this vulnerable population continues to have significant dental ... Journal of the American Dental Association , researchers ... University School of Dental Medicine report on the ... oral care provided by caregivers to adults with ...
(Date:10/1/2014)... 01, 2014 Bedros Keuilian is not ... Camp fitness boot camps, he’s also considered the leading ... with sold out business summits, a line of high-demand ... to a recent Spike TV reality show to his ... is the time for personal trainers and fitness business ...
(Date:10/1/2014)... Conn. (PRWEB) October 01, 2014 ... company, including a redefined mission and visual identity ... power of partnering with them to create greater ... agile brand that focuses on empowering customers to ... communications. , The crown jewel of the rebrand ...
(Date:10/1/2014)... 2014 Innovations announces the upcoming airing ... on Monday, October 20, 2014 at 7:30 a.m. EST/PT ... go behind the scenes to learn about Break the ... explore the practical help and information Break the Cycle ... warning signs of abuse, how to navigate the legal ...
(Date:10/1/2014)... On Sept. 9, Chapín Coffee was selected as ... American Made Awards (MSAMAs), an annual competition in recognition ... fields of crafts, design, food and style. , ... the MSAMAs, which celebrates entrepreneurs and artisans who are ... and changing the way we shop, work and live,” ...
Breaking Medicine News(10 mins):Health News:To improve oral health of adults with developmental disabilities, support caregivers 2Health News:To improve oral health of adults with developmental disabilities, support caregivers 3Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 2Health News:Bedros Keuilian Shares Tips on Selling Personal Training for the Holidays 3Health News:Farmington Company Launches Rebrand and New Positioning 2Health News:Innovations to Explore Breakthroughs in Health and Wellness in Upcoming Episode Airing Monday, October 20, 2014 via Discovery Channel 2Health News:Chicago Coffee Start-up Makes a Big Impact, Earns National Recognition 2
... Italy, September 21 Health Robotics today,announced that ... Device Technologies Australia Pty Ltd. for its revolutionary,CytoCare(TM) ... achieve its goal of safely, accurately and cost-effectively,automating ... its,other market-leading Oncology and Surgery Robotic solutions. , ...
... Solos Endoscopy, Inc. (Pink Sheets: SNDY) is pleased to announce ... its MammoView(TM) line of surgical endoscopy instruments from approximately 30 ... the last 12 months. More than half of the purchase ... and private Universities across the Country. , , ...
... , , KANSAS CITY, Mo., Sept. ... and Prevention (CDC), recommend seasonal influenza vaccination as the first line ... , The American Lung Association of the Central ... initiative in Kansas City and is supporting local public health efforts ...
... ST. LOUIS, Sept. 21 KV ... (Nasdaq: PRGO ) of KV,s first-to-file Paragraph IV Abbreviated ... for a generic equivalent version of GlaxoSmithKline,s Duac(R) gel. , ... will receive $14 million from Perrigo at closing and an additional, ...
... , , , Sponsored by ... , WEST CONSHOHOCKEN, Pa., Sept. 21 Austin Retina Associates ... SupportSight seminar in Austin on October 3rd. SupportSight ... macular degeneration and for those who would like to learn more about ...
... , , FRANKLIN, Mass., Sept. ... company focused on innovative cardiac and vascular medical device-based technologies, ... Transcatheter Cardiovascular Therapeutics (TCT) 2009, sponsored by the Cardiovascular Research ... More than 11,000 clinicians and professionals are expected to ...
Cached Medicine News:Health News:Health Robotics Continues Global Expansion Into Oceania With Device Technologies Australia's Strategic Partnership 2Health News:Health Robotics Continues Global Expansion Into Oceania With Device Technologies Australia's Strategic Partnership 3Health News:Solos Endoscopy, Inc.'s MammoView(TM) Product Line Receives New Purchase Orders Primarily from Prestigious Teaching Hospitals Across the Country 2Health News:The American Lung Association of the Central States Encourages Greater Kansas City Metro Residents to See Themselves Among the Many 'Faces' of Influenza 2Health News:The American Lung Association of the Central States Encourages Greater Kansas City Metro Residents to See Themselves Among the Many 'Faces' of Influenza 3Health News:The American Lung Association of the Central States Encourages Greater Kansas City Metro Residents to See Themselves Among the Many 'Faces' of Influenza 4Health News:The American Lung Association of the Central States Encourages Greater Kansas City Metro Residents to See Themselves Among the Many 'Faces' of Influenza 5Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 2Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 3Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 4Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 5Health News:KV Pharmaceutical Divests ANDA for Generic Version of Duac(R) 6Health News:SupportSight Comes to Austin, Saturday October 3 - Free Seminar for Those Affected by Macular Degeneration 2Health News:PLC Medical Systems to Demonstrate RenalGuard(R) at TCT 2009, Building on Success at ESC 2009 2Health News:PLC Medical Systems to Demonstrate RenalGuard(R) at TCT 2009, Building on Success at ESC 2009 3Health News:PLC Medical Systems to Demonstrate RenalGuard(R) at TCT 2009, Building on Success at ESC 2009 4
Improve your refractive outcome, with AXIS II precision biometry A-scan. Biometry clinically proven as accurate as partial coherence interferometry while not limited by dense media....
... with graphic display and IOL power ... combination units include firmware module with ... II formulas. Audible tones increase in ... visual axis. Constant tone when alignment ...
... ("I-cubed") is an exceptionally high resolution, ... oscilloscope (static deflection) display. This provides ... low cost video monitors. Vitreous structures ... cells, as well as tumor vascularity ...
... sensitive B-scan system which quickly identifies ocular asymmetry. ... eyes differ by more than 0.3 mm, a ... The B5500 enables quick and easy identification of ... or inserting shells under the lids. The B5500 ...
Medicine Products: